SpectraCure Past Earnings Performance
Past criteria checks 0/6
SpectraCure's earnings have been declining at an average annual rate of -9.3%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been declining at an average rate of 1.5% per year.
Key information
-9.3%
Earnings growth rate
-6.9%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | -1.5% |
| Return on equity | -20.4% |
| Net Margin | -1,474.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans
Jul 31
We're Hopeful That SpectraCure (STO:SPEC) Will Use Its Cash Wisely
Feb 23We're Not Very Worried About SpectraCure's (STO:SPEC) Cash Burn Rate
Nov 09Companies Like SpectraCure (STO:SPEC) Are In A Position To Invest In Growth
Jul 27Companies Like SpectraCure (STO:SPEC) Are In A Position To Invest In Growth
Mar 09SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans
Nov 08SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans
Jul 26We Think SpectraCure (STO:SPEC) Can Afford To Drive Business Growth
Mar 19Here's Why We're Not Too Worried About SpectraCure's (STO:SPEC) Cash Burn Situation
Nov 16We Think SpectraCure (STO:SPEC) Can Easily Afford To Drive Business Growth
Aug 03We're Not Worried About SpectraCure's (STO:SPEC) Cash Burn
Apr 16Companies Like SpectraCure (STO:SPEC) Can Afford To Invest In Growth
Jan 01Revenue & Expenses Breakdown
How SpectraCure makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2 | -23 | 31 | 0 |
| 30 Jun 24 | 0 | -21 | 29 | 0 |
| 31 Mar 24 | -2 | -21 | 29 | 0 |
| 31 Dec 23 | 0 | -20 | 31 | 0 |
| 30 Sep 23 | 1 | -23 | 32 | 0 |
| 30 Jun 23 | 1 | -23 | 31 | 0 |
| 31 Mar 23 | 8 | -24 | 32 | 0 |
| 31 Dec 22 | 1 | -25 | 29 | 0 |
| 30 Sep 22 | 0 | -25 | 28 | 0 |
| 30 Jun 22 | 0 | -25 | 29 | 0 |
| 31 Mar 22 | 0 | -25 | 29 | 0 |
| 31 Dec 21 | 0 | -23 | 28 | 0 |
| 30 Sep 21 | 1 | -22 | 27 | 0 |
| 30 Jun 21 | 1 | -19 | 24 | 0 |
| 31 Mar 21 | 1 | -16 | 22 | 0 |
| 31 Dec 20 | 1 | -15 | 20 | 0 |
| 30 Sep 20 | 1 | -15 | 19 | 0 |
| 30 Jun 20 | 1 | -15 | 19 | 0 |
| 31 Mar 20 | 1 | -15 | 18 | 0 |
| 31 Dec 19 | 1 | -14 | 17 | 0 |
| 30 Sep 19 | 1 | -16 | 21 | 0 |
| 31 Dec 18 | 1 | -13 | 17 | 0 |
| 30 Sep 18 | 1 | -9 | 11 | 0 |
| 31 Dec 17 | 3 | -9 | 10 | 0 |
| 30 Sep 17 | 3 | -8 | 9 | 0 |
| 30 Jun 17 | 3 | -7 | 8 | 0 |
| 31 Mar 17 | 3 | -7 | 8 | 0 |
| 31 Dec 16 | 3 | -6 | 8 | 0 |
| 30 Sep 16 | 3 | -7 | 8 | 0 |
| 30 Jun 16 | 2 | -7 | 8 | 0 |
| 31 Mar 16 | 2 | -7 | 8 | 0 |
| 31 Dec 15 | 1 | -6 | 7 | 0 |
| 30 Sep 15 | 1 | -6 | 7 | 0 |
| 30 Jun 15 | 1 | -6 | 6 | 0 |
| 31 Mar 15 | 1 | -4 | 4 | 0 |
| 31 Dec 14 | 1 | -4 | 4 | 0 |
| 31 Dec 13 | 1 | -6 | 5 | 0 |
Quality Earnings: SPEC is currently unprofitable.
Growing Profit Margin: SPEC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SPEC is unprofitable, and losses have increased over the past 5 years at a rate of 9.3% per year.
Accelerating Growth: Unable to compare SPEC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SPEC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).
Return on Equity
High ROE: SPEC has a negative Return on Equity (-20.39%), as it is currently unprofitable.